Skip to content

Razvili cepivo proti eni najnevarnejših oblik kožnega raka

October 29, 2026 · 16 min

Show notes

Kako cepivo deluje, kaj točno razkrivajo rezultati kliničnih raziskav in kdaj bo dobilo dovoljenje za uporabo?

Personalizirano mRNK-cepivo proti malignemu melanomu v kombinaciji z imunoterapijo obeta pomemben napredek pri zdravljenju ene najnevarnejših oblik kožnega raka. Študije so pokazale zmanjšanje tveganja za ponovitev bolezni in za smrtni izid. Kako cepivo deluje, kaj točno razkrivajo rezultati kliničnih raziskav in kdaj bo novo cepivo dobilo dovoljenje za uporabo? V Ultrazvoku pojasnjuje prof. dr. Janja Ocvirk, specialistka internistične onkologije in strokovna direktorica Onkološkega inštituta Ljubljana.

Foto: Slika je simbolična/ MMC

All episodes of Ultrazvok

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.